JAK2 and myeloproliferative disorder: Mutations that activate signaling via the JAK2 tyrosine kinase drive MPN formation - resulting in clonal hematopoiesis and trilineage myeloproliferation leading to leukocytosis, thrombocytosis, and erythrocytosis [2–4].